Janux Therapeutics (JANX) Receivables - Other (2023 - 2025)
Historic Receivables - Other for Janux Therapeutics (JANX) over the last 3 years, with Q3 2025 value amounting to $6.3 million.
- Janux Therapeutics' Receivables - Other rose 4178.27% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 4178.27%. This contributed to the annual value of $5.4 million for FY2024, which is 14900.51% up from last year.
- Per Janux Therapeutics' latest filing, its Receivables - Other stood at $6.3 million for Q3 2025, which was up 4178.27% from $5.7 million recorded in Q2 2025.
- Over the past 5 years, Janux Therapeutics' Receivables - Other peaked at $6.3 million during Q3 2025, and registered a low of $2.2 million during Q4 2023.
- In the last 3 years, Janux Therapeutics' Receivables - Other had a median value of $5.0 million in 2024 and averaged $4.8 million.
- Per our database at Business Quant, Janux Therapeutics' Receivables - Other skyrocketed by 14900.51% in 2024 and then skyrocketed by 2491.22% in 2025.
- Quarter analysis of 3 years shows Janux Therapeutics' Receivables - Other stood at $2.2 million in 2023, then surged by 149.01% to $5.4 million in 2024, then increased by 17.36% to $6.3 million in 2025.
- Its Receivables - Other was $6.3 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.6 million in Q1 2025.